Side effects of adjuvant endocrine treatment in premenopausal breast cancer patients: a prospective randomized study.

@article{Nystedt2003SideEO,
  title={Side effects of adjuvant endocrine treatment in premenopausal breast cancer patients: a prospective randomized study.},
  author={Marianne Nystedt and G. Z. M. Berglund and Christina Bolund and Tommy Fornander and Lars Erik Rutqvist},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2003},
  volume={21 9},
  pages={1836-44}
}
PURPOSE To compare the effect of adjuvant endocrine therapies with and without chemotherapy on physical symptoms, anxiety, and depressive symptoms in premenopausal women with breast cancer in a randomized clinical trial (the Zoladex in Premenopausal Patients trial). PATIENTS AND METHODS The patients were randomly assigned to goserelin, goserelin plus tamoxifen, tamoxifen alone, or no endocrine therapy. The duration of the endocrine treatment was 2 years. The groups were observed for 3 years… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 29 extracted citations

Similar Papers

Loading similar papers…